Keung Man-Hong, Chan Lai-Sheung, Kwok Hoi-Hin, Wong Ricky Ngok-Shun, Yue Patrick Ying-Kit
Department of Biology, Faculty of Science, Hong Kong Baptist University, Hong Kong Special Administrative Region.
Department of Biology, Faculty of Science, Hong Kong Baptist University, Hong Kong Special Administrative Region; Dr. Gilbert Hung Ginseng Laboratory, Hong Kong Baptist University, Hong Kong Special Administrative Region.
J Ginseng Res. 2016 Apr;40(2):151-9. doi: 10.1016/j.jgr.2015.07.002. Epub 2015 Jul 29.
Ginsenoside-Rg3, the pharmacologically active component of red ginseng, has been found to inhibit tumor growth, invasion, metastasis, and angiogenesis in various cancer models. Previously, we found that 20(R)-ginsenoside-Rg3 (Rg3) could inhibit angiogenesis. Since microRNAs (miRNAs) have been shown to affect many biological processes, they might play an important role in ginsenoside-mediated angiomodulation.
In this study, we examined the underlying mechanisms of Rg3-induced angiosuppression through modulating the miRNA expression. In the miRNA-expression profiling analysis, six miRNAs and three miRNAs were found to be up- or down-regulated in vascular-endothelial-growth-factor-induced human-umbilical-vein endothelial cells (HUVECs) after Rg3 treatment, respectively.
A computational prediction suggested that mature hsa-miR-520h (miR-520h) targets ephrin receptor (Eph) B2 and EphB4, and hence, affecting angiogenesis. The up-regulation of miR-520h after Rg3 treatment was validated by quantitative real-time polymerase chain reaction, while the protein expressions of EphB2 and EphB4 were found to decrease, respectively. The mimics and inhibitors of miR-520h were transfected into HUVECs and injected into zebra-fish embryos. The results showed that overexpression of miR-520h could significantly suppress the EphB2 and EphB4 protein expression, proliferation, and tubulogenesis of HUVECs, and the subintestinal-vessel formation of the zebra fish.
These results might provide further information on the mechanism of Rg3-induced angiosuppression and the involvement of miRNAs in angiogenesis.
人参皂苷-Rg3是红参的药理活性成分,已发现在多种癌症模型中可抑制肿瘤生长、侵袭、转移和血管生成。此前,我们发现20(R)-人参皂苷-Rg3(Rg3)可抑制血管生成。由于微小RNA(miRNA)已被证明可影响许多生物学过程,它们可能在人参皂苷介导的血管调节中发挥重要作用。
在本研究中,我们通过调节miRNA表达来研究Rg3诱导血管抑制的潜在机制。在miRNA表达谱分析中,发现分别有6个miRNA和3个miRNA在Rg3处理后的血管内皮生长因子诱导的人脐静脉内皮细胞(HUVEC)中上调或下调。
一项计算预测表明,成熟的hsa-miR-520h(miR-520h)靶向 Ephrin受体(Eph)B2和EphB4,从而影响血管生成。通过定量实时聚合酶链反应验证了Rg3处理后miR-520h的上调,同时发现EphB2和EphB4的蛋白表达分别降低。将miR-520h的模拟物和抑制剂转染到HUVEC中并注射到斑马鱼胚胎中。结果表明,miR-520h的过表达可显著抑制HUVEC的EphB2和EphB4蛋白表达、增殖和管形成,以及斑马鱼的肠下血管形成。
这些结果可能为Rg3诱导血管抑制的机制以及miRNA在血管生成中的作用提供进一步的信息。